Yuzo Suzuki

6.1k citations

189 papers · 3.9k indexed · h-index 33

Biological Psychiatry top 1%
Pulmonary and Respiratory Medicine top 1%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 77
- Chronic Obstructive Pulmonary Disease (COPD) Research 31
- Lung Cancer Treatments and Mutations 19
- Lung Cancer Diagnosis and Treatment 16
- Inhalation and Respiratory Drug Delivery 16
- Occupational and environmental lung diseases 15
Immunology top 5%
Physiology top 2%
- Sarcoidosis and Beryllium Toxicity Research 26
- Asthma and respiratory diseases 25
Behavioral Neuroscience top 5%

Co-authors: Takafumi Suda Naoki Inui Kazuki Furuhashi Yutaro Nakamura Tomoyuki Fujisawa Noriyuki Enomoto Masato Karayama Hironao Hozumi
Cited by: Biological Psychiatry Pulmonary and Respiratory Medicine Immunology
Journals: Nature Communications (1 paper)SHILAP Revista de lepidopterología (2 papers)Blood (1 paper)
Partner nations: Japan United States Italy

In The Last Decade

Yuzo Suzuki

177 papers receiving 3.8k citations

Peers

Countries citing papers authored by Yuzo Suzuki

Since Specialization

Citations

This map shows the geographic impact of Yuzo Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuzo Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuzo Suzuki more than expected).

Fields of papers citing papers by Yuzo Suzuki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuzo Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuzo Suzuki. The network helps show where Yuzo Suzuki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yuzo Suzuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuzo Suzuki Line = papers co-authored together Yuzo Suzuki links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Outcomes of COVID-19 in the Omicron-predominant wave: large-scale real-world data analysis with a comparison to influenza PubMed ·Koichi Miyashita,Hironao Hozumi,Kazuki Furuhashi,Eiji Nakatani,Yusuke Inoue,Hideki Yasui,Yuzo Suzuki,Masato Karayama,Noriyuki Enomoto,Tomoyuki Fujisawa,Naoki Inui,Toshiyuki Ojima,Takafumi Suda	2025	0
2	Massive immune-related myositis and cytokine release syndrome during dual immunotherapy plus chemotherapy for recurrent lung adenocarcinoma: case report Respiratory Medicine Case Reports ·Shogo Nakai,Yusuke Inoue,Masato Karayama,Hideki Yasui,Yuzo Suzuki,Hironao Hozumi,Kazuki Furuhashi,Noriyuki Enomoto,Tomoyuki Fujisawa,Naoki Inui,Takafumi Suda	2025	0
3	Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study Respiratory Research ·Koichi Miyashita,Hironao Hozumi,Kazuki Furuhashi,Eiji Nakatani,Yusuke Inoue,Hideki Yasui,Yuzo Suzuki,Masato Karayama,Noriyuki Enomoto,Tomoyuki Fujisawa,Naoki Inui,Toshiyuki Ojima,Takafumi Suda	2024	3
4	Idiopathic pleuroparenchymal fibroelastosis: A review of the previous literature and current knowledge Respiratory Investigation ·Yuzo Suzuki	2024	1
5	Characterization of BRAF^Thr599dup Mutation as a Targetable Driver Mutation Identified in Lung Adenocarcinoma by Comprehensive Genomic Profiling JCO Precision Oncology ·Hirofumi Watanabe,Yusuke Inoue,Masato Karayama,Shusuke Yazawa,Yasutaka Mochizuka,Hideki Yasui,Hironao Hozumi,Yuzo Suzuki,Kazuki Furuhashi,Noriyuki Enomoto,Tomoyuki Fujisawa,Kazuya Shinmura,Naoki Inui,Takafumi Suda	2024	0
6	CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling The Journal of Immunology ·Hyogo Naoi,Yuzo Suzuki,Asuka Miyagi,Ryo Horiguchi,Yuya Aono,Yusuke Inoue,Hideki Yasui,Hironao Hozumi,Masato Karayama,Kazuki Furuhashi,Noriyuki Enomoto,Tomoyuki Fujisawa,Naoki Inui,Shinji Mii,Masatoshi Ichihara,Masahide Takahashi,Takafumi Suda	2024	3
7	Neutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis BMJ Open Respiratory Research ·Yuzo Suzuki,Masato Kono,Hirotsugu Hasegawa,Dai Hashimoto,Koshi Yokomura,Shiro Imokawa,Yusuke Inoue,Hironao Hozumi,Masato Karayama,Kazuki Furuhashi,Noriyuki Enomoto,Tomoyuki Fujisawa,Naoki Inui,Takafumi Suda	2023	6
8	Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis Respirology ·Yasutaka Mochizuka,Yuzo Suzuki,Masato Kono,Hirotsugu Hasegawa,Dai Hashimoto,Koshi Yokomura,Yusuke Inoue,Hideki Yasui,Hironao Hozumi,Masato Karayama,Kazuki Furuhashi,Noriyuki Enomoto,Tomoyuki Fujisawa,Naoki Inui,Hidenori Nakamura,Takafumi Suda	2023	23
9	Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis Thorax ·Hyogo Naoi,Yuzo Suzuki,Kazutaka Mori,Yuya Aono,Masato Kono,Hirotsugu Hasegawa,Koshi Yokomura,Yusuke Inoue,Hironao Hozumi,Masato Karayama,Kazuki Furuhashi,Noriyuki Enomoto,Tomoyuki Fujisawa,Yutaro Nakamura,Naoki Inui,Hidenori Nakamura,Takafumi Suda	2022	20
10	Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease Respiratory Medicine ·Aiko Saku,Tomoyuki Fujisawa,Koji Nishimoto,Katsuhiro Yoshimura,Hironao Hozumi,Masato Karayama,Yuzo Suzuki,Kazuki Furuhashi,Noriyuki Enomoto,Yutaro Nakamura,Naoki Inui,Takafumi Suda	2021	16
11	Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis Respiratory Investigation ·Kazuki Tanaka,Noriyuki Enomoto,Hironao Hozumi,Takuya Isayama,Hyogo Naoi,Yuya Aono,Mineo Katsumata,Hideki Yasui,Masato Karayama,Yuzo Suzuki,Kazuki Furuhashi,Tomoyuki Fujisawa,Naoki Inui,Yutaro Nakamura,Takafumi Suda	2021	17
12	A GWAS approach identifies Dapp1 as a determinant of air pollution-induced airway hyperreactivity PLoS Genetics ·Hadi Maazi,Jaana Hartiala,Yuzo Suzuki,Amanda L. Crow,Pedram Shafiei-Jahani,Jonathan Lam,Nisheel Patel,Diamanda Rigas,Yi Han,Pin Huang,Eleazar Eskin,Aldons J. Lusis,Frank D. Gilliland,Omid Akbari,Hooman Allayee	2019	11
13	Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody–positive Polymyositis/dermatomyositis–associated Interstitial Lung Disease: A Propensity Score–matched Analysis The Journal of Rheumatology ·Hironao Hozumi,Tomoyuki Fujisawa,Ran Nakashima,Hideki Yasui,Yuzo Suzuki,Masato Kono,Masato Karayama,Kazuki Furuhashi,Noriyuki Enomoto,Naoki Inui,Yutaro Nakamura,Tsuneyo Mimori,Takafumi Suda	2019	25
14	Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias Respiratory Medicine ·Mineo Katsumata,Hironao Hozumi,Hideki Yasui,Yuzo Suzuki,Masato Kono,Masato Karayama,Kazuki Furuhashi,Noriyuki Enomoto,Tomoyuki Fujisawa,Naoki Inui,Yutaro Nakamura,Takafumi Suda	2019	9
15	IL-17A Attenuates IFN-λ Expression by Inducing Suppressor of Cytokine Signaling Expression in Airway Epithelium The Journal of Immunology ·Mitsuru Niwa,Tomoyuki Fujisawa,Kazutaka Mori,Katsumasa Yamanaka,Hideki Yasui,Yuzo Suzuki,Masato Karayama,Hironao Hozumi,Kazuki Furuhashi,Noriyuki Enomoto,Yutaro Nakamura,Naoki Inui,Tetsuro Suzuki,Masato Maekawa,Takafumi Suda	2018	21
16	Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysis Medical Oncology ·Masato Karayama,Naoki Inui,Kazuki Tanaka,Hideki Yasui,Hironao Hozumi,Yuzo Suzuki,Kazuki Furuhashi,Tomoyuki Fujisawa,Noriyuki Enomoto,Yutaro Nakamura,Takafumi Suda	2018	4
17	Neutrophil gelatinase-associated lipocalin in patients with sarcoidosis Respiratory Medicine ·Shinpei Kato,Naoki Inui,Hironao Hozumi,Yusuke Inoue,Hideki Yasui,Masato Karayama,Masato Kono,Yuzo Suzuki,Kazuki Furuhashi,Noriyuki Enomoto,Tomoyuki Fujisawa,Yutaro Nakamura,Hiroshi Watanabe,Takafumi Suda	2018	5
18	Cumulative incidence of tuberculosis in lung cancer patients in Japan: A 6-year observational study Respiratory Investigation ·Yuzo Suzuki,Shiro Imokawa,Jun Sato,Tomohiro Uto,Takafumi Suda	2015	12
19	Mouse Lung CD103+ and CD11bhigh Dendritic Cells Preferentially Induce Distinct CD4+ T-Cell Responses American Journal of Respiratory Cell and Molecular Biology ·Kazuki Furuhashi,Takafumi Suda,Hirotsugu Hasegawa,Yuzo Suzuki,Dai Hashimoto,Noriyuki Enomoto,Tomoyuki Fujisawa,Yutaro Nakamura,Naoki Inui,Kiyoshi Shibata,Hirotoshi Nakamura,Kingo Chida	2011	91
20	[Severe theophylline toxicity in a pregnant asthmatic patient]. PubMed ·Hiroyasu Nagahama,Kasuke Nagano,I Yamanaka,J. Kasagawa,Ichiro Seki,Yuzo Suzuki	1993	1

About Yuzo Suzuki

Yuzo Suzuki is a scholar working on Pulmonary and Respiratory Medicine, Biological Psychiatry and Physiology, having authored 189 papers that have together received 3.9k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (77 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (31 papers), Sarcoidosis and Beryllium Toxicity Research (26 papers), Asthma and respiratory diseases (25 papers), Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Diagnosis and Treatment (16 papers), Inhalation and Respiratory Drug Delivery (16 papers) and Occupational and environmental lung diseases (15 papers). The work is most often cited by research in Biological Psychiatry (262 citations), Pulmonary and Respiratory Medicine (1.9k citations) and Immunology (908 citations). Yuzo Suzuki has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Takafumi Suda, Naoki Inui, Kazuki Furuhashi, Yutaro Nakamura, Tomoyuki Fujisawa, Noriyuki Enomoto, Masato Karayama, Hironao Hozumi, Hideki Yasui and Kingo Chida. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact